Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Growth | Market Cap | Revenue | EBITDA | Earnings | EPS | Rev. Y/Y | Rev. 5Y | Earn. Y/Y | Earn. 5Y | Earnings Date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FBLG | FIBROBIOLOGICS INC | $4.46M | $0.00 | -$17.61M | -$18.65M | -$8.40 | N/A | N/A | N/A | N/A | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $9.35M | $0.00 | -$19.83M | -$19.86M | -$5.48 | N/A | N/A | N/A | N/A | |||
| PSTV | PLUS THERAPEUTICS INC | $27.96M | $5.21M | -$18.33M | -$22.39M | -$0.29 | -10.49% | 76.66% | N/A | N/A | |||
| CODX | CO-DIAGNOSTICS INC | $6.70M | $622.49k | -$47.41M | -$46.90M | -$35.25 | -84.10% | -61.60% | N/A | N/A | |||
| SGMO | SANGAMO THERAPEUTICS INC | $102.33M | $39.55M | -$115.90M | -$122.93M | -$0.44 | -31.57% | -19.66% | N/A | N/A | 2026-05-18 | ||
| NRXP | NRX PHARMACEUTICALS INC | $70.43M | $1.23M | -$27.81M | -$28.62M | -$1.34 | N/A | N/A | N/A | N/A | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $3.11M | $11.57M | -$10.72M | -$15.86M | -$303.00 | -48.05% | 49.54% | N/A | N/A | 2026-05-14 | ||
| IMMP | IMMUTEP LTD | $51.73M | $7.65M | N/A | -$59.52M | -$0.41 | 5.96% | 3.01% | N/A | N/A | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $33.77M | $0.00 | -$31.52M | -$34.50M | -$0.74 | N/A | N/A | N/A | N/A | 2026-05-20 | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $90.91M | $1.63M | -$23.97M | -$29.67M | -$0.45 | 58.85% | 28.73% | N/A | N/A | 2026-05-13 | ||
| ENLV | ENLIVEX LTD | $220.76M | $0.00 | $1.62B | $1.24B | $27.04 | N/A | N/A | N/A | N/A | |||
| OSTX | OS THERAPIES INC | $55.74M | $0.00 | -$28.39M | -$28.75M | -$0.98 | N/A | N/A | N/A | N/A | 2026-04-06 | ||
| GUTS | FRACTYL HEALTH INC | $72.66M | $0.00 | -$138.24M | -$140.95M | -$1.86 | -100.00% | N/A | N/A | N/A | 2026-04-06 | ||
| HELP | CYBIN INC | $239.49M | $0.00 | -$96.64M | -$96.75M | -$3.64 | N/A | N/A | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $29.83M | $0.00 | -$18.05M | -$18.21M | -$2.46 | N/A | -100.00% | N/A | N/A | |||
| SNTI | SENTI BIOSCIENCES INC | $25.29M | $22.00k | -$57.80M | -$61.44M | -$2.73 | N/A | -47.77% | N/A | N/A | |||
| NRSN | NEUROSENSE THERAPEUTICS LTD | $18.57M | $0.00 | -$8.86M | -$8.66M | -$0.36 | N/A | N/A | N/A | N/A | |||
| HOVR | NEW HORIZON AIRCRAFT LTD | $62.40M | $0.00 | -$22.42M | -$22.71M | -$0.70 | N/A | N/A | N/A | N/A | |||
| HUMA | HUMACYTE INC | $134.77M | $2.04M | -$22.19M | -$40.83M | -$0.26 | N/A | 6.45% | N/A | N/A | 2026-05-08 | ||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $4.61M | $627.40k | -$7.27M | -$7.86M | -$11.73 | 111.54% | -19.42% | N/A | N/A | |||
| ACRV | ACRIVON THERAPEUTICS INC | $53.85M | $0.00 | -$75.52M | -$77.91M | -$2.02 | N/A | N/A | N/A | N/A | |||
| FEMY | FEMASYS INC | $24.56M | $2.06M | -$17.01M | -$19.80M | -$0.72 | 63.53% | N/A | N/A | N/A | |||
| CTSO | CYTOSORBENTS CORP | $35.49M | $37.06M | -$4.62M | -$8.20M | -$0.13 | 4.12% | -2.00% | N/A | N/A | 2026-05-05 | ||
| ACET | ADICET BIO INC | $65.35M | $0.00 | -$107.00M | -$116.80M | -$16.95 | N/A | -100.00% | N/A | N/A | |||
| VNRX | VOLITIONRX LTD | $24.81M | $1.47M | -$21.14M | -$22.88M | -$0.23 | 14.48% | 197.53% | N/A | N/A | 2026-05-13 | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $36.28M | $642.00k | -$52.61M | -$69.90M | -$5.73 | -71.67% | N/A | N/A | N/A | |||
| NSRX | NASUS PHARMA LTD | $20.01M | $0.00 | -$5.92M | -$5.86M | -$0.72 | N/A | N/A | N/A | N/A | |||
| INTZ | INTRUSION INC | $16.72M | $7.10M | -$7.22M | -$9.06M | -$0.46 | 22.94% | 1.40% | N/A | N/A | |||
| CAN | CANAAN INC | $287.68M | $529.74M | N/A | -$210.27M | -$0.48 | 96.69% | 52.18% | N/A | N/A | 2026-04-15 | ||
| IFRX | INFLARX NV | $64.63M | $33.71k | -$51.91M | -$52.45M | -$0.78 | -80.02% | N/A | N/A | N/A | 2026-05-13 | ||
| TNYA | TENAYA THERAPEUTICS INC | $150.16M | $0.00 | -$79.69M | -$90.60M | -$0.59 | N/A | N/A | N/A | N/A | |||
| GNLX | GENELUX CORP | $108.43M | $0.00 | -$31.57M | -$32.15M | -$0.86 | N/A | N/A | N/A | N/A | 2026-04-06 | ||
| RCT | REDCLOUD HOLDINGS PLC | $31.40M | $48.40M | -$50.06M | -$53.37M | -$2.32 | 62.92% | N/A | N/A | N/A | 2026-05-01 | ||
| CLNN | CLENE INC | $58.07M | $200.00k | -$21.43M | -$26.17M | -$2.65 | -41.52% | -0.59% | N/A | N/A | |||
| AVXL | ANAVEX LIFE SCIENCES CORP | $284.50M | $0.00 | -$39.93M | -$39.95M | -$0.46 | N/A | N/A | N/A | N/A | 2026-05-07 | ||
| CCCC | C4 THERAPEUTICS INC | $256.63M | $35.95M | -$96.48M | -$104.99M | -$1.27 | 1.02% | 1.61% | N/A | N/A | 2026-05-13 | ||
| FGNX | FG NEXUS INC | $32.59M | $2.41M | -$66.38M | -$68.51M | -$25.69 | 209.76% | N/A | N/A | N/A | |||
| AUTL | AUTOLUS THERAPEUTICS PLC | $367.28M | $75.39M | -$244.81M | -$287.53M | -$1.08 | 644.94% | 113.11% | N/A | N/A | 2026-04-30 | ||
| CABA | CABALETTA BIO INC | $299.46M | $0.00 | -$148.84M | -$167.86M | -$2.10 | N/A | N/A | N/A | N/A | 2026-05-20 | ||
| MIST | MILESTONE PHARMACEUTICALS INC | $140.02M | $1.55M | -$59.11M | -$63.06M | -$0.75 | N/A | N/A | N/A | N/A | 2026-05-18 | ||
| PEPG | PEPGEN INC | $122.33M | $0.00 | -$88.21M | -$89.66M | -$2.12 | N/A | N/A | N/A | N/A | 2026-05-07 | ||
| HOWL | WEREWOLF THERAPEUTICS INC | $40.48M | $0.00 | -$53.13M | -$60.82M | -$1.32 | -100.00% | N/A | N/A | N/A | |||
| PALI | PALISADE BIO INC | $290.30M | $0.00 | -$16.68M | -$16.78M | -$0.30 | N/A | N/A | N/A | N/A | |||
| BMEA | BIOMEA FUSION INC | $110.62M | $0.00 | -$58.54M | -$61.80M | -$1.18 | N/A | N/A | N/A | N/A | 2026-04-06 | ||
| ATOS | ATOSSA THERAPEUTICS INC | $45.30M | $0.00 | -$34.75M | -$34.77M | -$4.04 | N/A | N/A | N/A | N/A | 2026-04-01 | ||
| IVVD | INVIVYD INC | $367.37M | $53.43M | -$50.38M | -$52.49M | -$0.30 | 110.47% | N/A | N/A | N/A | 2026-05-07 | ||
| MNOV | MEDICINOVA INC | $67.43M | $409.66k | -$11.80M | -$12.00M | -$0.24 | N/A | N/A | N/A | N/A | 2026-05-13 | ||
| ALIT | ALIGHT INC | $311.62M | $2.26B | -$2.58B | -$3.10B | -$5.87 | -3.00% | -3.68% | N/A | N/A | 2026-05-13 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.